Gilead Science CEO Daniel O'Day will testify May 16 on Capitol Hill  in front of a House committee over the pricing for its HIV prevention pill, according to STAT.

In an effort to lower prescription drug costs in the U.S., CMS issued a new guidance May 15 to limit the prevalence of spread pricing in Medicaid managed care plans.

Pennsylvania Attorney General Josh Shapiro accused Purdue Pharma of fueling the opioid epidemic in the state in a lawsuit filed May 14, according to The Hill.

ProvideGx, a subsidiary of Premier, will collaborate with Fresenius Kabi to help mitigate national shortages of five generic injectable medications.

Civica Rx, the nonprofit generic drugmaker formed by a group of health systems, will begin by distributing two essential antibiotics, the company announced May 15.

Johnson & Johnson and Teva Pharmaceuticals lost a last-minute bid to escape an opioid lawsuit brought against them by the state of Oklahoma, according to Reuters.

Kentucky is suing three insulin makers — Eli Lilly, Sanofi and Novo Nordisk —  over alleged price-gouging, according to The Hill. The state is the latest to sue insulin manufacturers over the pricing of the product.

AbbVie and Boehringer Ingelheim have resolved their patent dispute over a biosimilar to Humira, the companies announced May 14.

Medications purchased at discounted rates under the federal 340B program hit a record $24.3 billion in 2018, up 26 percent from 2017, according to Health Resources and Service Administration data cited by pharmaceutical website Drug Channels.

A San Francisco jury ordered Bayer to pay more than $2 billion to a couple who claimed the company's weedkiller caused their cancer, according to CNBC.